No(cebo) Vax: COVID-19 Vaccine Beliefs Are Important Determinants of Both Occurrence and Perceived Severity of Common Vaccines’ Adverse Effects

Abstract

This study highlights the role of psychological influences in triggering and amplifying the adverse effects of the COVID-19 vaccine (i.e., nocebo effects). Fear, beliefs, and expectations about the COVID-19 vaccine, trust in health and scientific institutions, and stable personality traits were measured in 315 adult Italian citizens (145 men) during the 15-min waiting time after vaccination. The occurrence and severity of 10 potential adverse effects were assessed 24 hr later. Nonpharmacological variables predicted nearly 30% of the severity of the vaccine’s adverse effects. Expectations are important determinants of adverse effects from vaccines, and the results of the path analyses show that these expectations stem primarily from people’s vaccine beliefs and attitudes, which can be changed. Implications for increasing vaccine acceptability and limiting the nocebo effect are discussed.

Keywords

COVID-19 vaccine nocebo

Get full access to this article

View all access options for this article.

References

Amanzio

Mitsikostas

D. D.

Giovannelli

Bartoli

Cipriani

G. E.

Brown

W. A.

(2022). Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. The Lancet Regional Health - Europe, 12, Article 100253. https://doi.org/10.1016/j.lanepe.2021.100253

Atlas

L. Y.

(2021). A social affective neuroscience lens on placebo analgesia. Trends in Cognitive Sciences, 25(11), 992–1005. https://doi.org/10.1016/j.tics.2021.07.016

Bajcar

E. A.

Wiercioch-Kuzianik

Farley

Buglewicz

Paulewicz

Bąbel

(2021). Order does matter: The combined effects of classical conditioning and verbal suggestions on placebo hypoalgesia and nocebo hyperalgesia. Pain, 162(8), 2237–2245. https://doi.org/10.1097/j.pain.0000000000002211

Bentler

P. M.

Chou

C.-P.

(1987). Practical issues in structural equation modeling. Sociological Methods and Research, 16, 78–117. https://doi.org/10.1177/0049124187016001004

Betsch

Sachse

(2013). Debunking vaccination myths: Strong risk negations can increase perceived vaccination risks. Health Psychology, 32(2), 146–155. https://doi.org/10.1037/a0027387

Bingel

(for the Placebo Competence Team). (2014). Avoiding nocebo effects to optimize treatment outcome. Journal of the American Medical Association, 312(7), 693–694. https://doi.org/10.1001/JAMA.2014.8342

Blasini

Corsi

Klinger

Colloca

(2017). Nocebo and pain: An overview of the psychoneurobiological mechanisms. Pain Reports, 2(2), Article e585. https://doi.org/10.1097/PR9.0000000000000585

Carver

C. S.

Pozo-Kaderman

Harris

S. D.

Noriega

Scheier

M. F.

Robinson

D. S.

Ketcham

A. S.

Moffat

F. L.

Clark

K. C.

(1994). Optimism versus pessimism predicts the quality of women’s adjustment to early stage breast cancer. Cancer, 73(4), 1213–1220. https://doi.org/10.1002/1097-0142(19940215)73:4<1213::AID-CNCR2820730415>3.0.CO;2-Q

Colloca

Barsky

A. J.

(2020). Placebo and nocebo effects. New England Journal of Medicine, 382(6), 554–561. https://doi.org/10.1056/NEJMra1907805

10.

Colloca

Miller

F. G.

(2011). The nocebo effect and its relevance for clinical practice. Psychosomatic Medicine, 73(7), 598–603. https://doi.org/10.1097/psy.0b013e3182294a50

11.

Devlin

E. J.

Whitford

H. S.

Peoples

A. R.

Morrow

G. R.

Katragadda

Giguere

J. K.

Naqvi

Roscoe

(2021). Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility. European Journal of Cancer Care, 30(6), Article e13488. https://doi.org/10.1111/ecc.13488

12.

Faasse

Petrie

K. J.

(2013). The nocebo effect: Patient expectations and medication side effects. Postgraduate Medical Journal, 89, 540–546. https://doi.org/10.1136/postgradmedj-2012-131730

13.

Geers

A. L.

Clemens

K. S.

Faasse

Colagiuri

Webster

Vase

Sieg

Jason

Colloca

(2022). Psychosocial factors predict COVID-19 vaccine side effects. Psychotherapy and Psychosomatics, 91, 136–138. https://doi.org/10.1159/000519853

14.

Goldenberg

M. J.

(2016). Public misunderstanding of science? Reframing the problem of vaccine hesitancy. Perspectives on Science, 24(5), 552–581. https://doi.org/10.1162/POSC_a_00223

15.

Haas

J. W.

Bender

F. L.

Ballou

Kelley

J. M.

Wilhelm

Miller

F. G.

Rief

Kaptchuk

T. J.

(2022). Frequency of adverse events in the placebo arms of COVID-19 vaccine trials: A systematic review and meta-analysis. JAMA Network Open, 5(1), Article e2143955. https://doi.org/10.1001/JAMANETWORKOPEN.2021.43955

16.

Horne

Powell

Hummel

J. E.

Holyoak

K. J.

(2015). Countering antivaccination attitudes. Proceedings of the National Academy of Sciences, USA, 112(33), 10321–10324. https://doi.org/10.1073/pnas.1504019112

17.

Hornsey

M. J.

Harris

E. A.

Fielding

K. S.

(2018). The psychological roots of anti-vaccination attitudes: A 24-nation investigation. Health Psychology, 37(4), 307–315. https://doi.org/10.1037/hea0000586.supp

18.

L.-T.

Bentler

P. M.

(1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55. https://doi.org/10.1080/10705519909540118

19.

Jackson

L. A.

Anderson

E. J.

Rouphael

N. G.

Roberts

P. C.

Makhene

Coler

R. N.

McCullough

M. P.

Chappell

J. D.

Denison

M. R.

Stevens

L. J.

Pruijssers

A. J.

McDermott

Flach

Doria-Rose

N. A.

Corbett

K. S.

Morabito

K. M.

O’Dell

Schmidt

S. D.

Swanson

P. A.

. . . Beigel

J. H.

(2020). An mRNA vaccine against SARS-CoV-2—Preliminary report. New England Journal of Medicine, 383(20), 1920–1931. https://doi.org/10.1056/nejmoa2022483

20.

Jensen

K. B.

Kaptchuk

T. J.

Kirsch

Raicek

Lindstrom

K. M.

Berna

Gollub

R. L.

Ingvar

Kong

(2012). Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences, USA, 109(39), 15959–15964. https://doi.org/10.1073/pnas.1202056109

21.

Kirsch

(1985). Response expectancy as a determinant of experience and behavior. American Psychologist, 40(11), 1189–1202. https://doi.org/10.1037/0003-066X.40.11.1189

22.

Klugar

Riad

Mekhemar

Conrad

Buchbender

Howaldt

H. P.

Attia

(2021). Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology, 10(8), Article 752. https://doi.org/10.3390/biology10080752

23.

Krauss

B. S.

(2015). “This may hurt:” Predictions in procedural disclosure may do harm. The BMJ, 350, Article h649. https://doi.org/10.1136/bmj.h649

24.

Larson

H. J.

Jarrett

Eckersberger

Smith

D. M. D.

Paterson

(2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine, 32(19), 2150–2159. https://doi.org/10.1016/j.vaccine.2014.01.081

25.

Levine-Tiefenbrun

Yelin

Katz

Herzel

Golan

Schreiber

Wolf

Nadler

Ben-Tov

Kuint

Gazit

Patalon

Chodick

Kishony

(2021). Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nature Medicine, 27(5), 790–792. https://doi.org/10.1038/s41591-021-01316-7

26.

Machingaidze

Wiysonge

C. S.

(2021). Understanding COVID-19 vaccine hesitancy. Nature Medicine, 27(8), 1338–1339. https://doi.org/10.1038/s41591-021-01459-7

27.

MacKinnon

D. P.

Luecken

L. J.

(2008). How and for whom? Mediation and moderation in health psychology. Health Psychology, 27(2, Suppl.), S99–S100. https://doi.org/10.1037/0278-6133.27.2(Suppl.).S99

28.

Morley

G. L.

Taylor

Jossi

Perez-Toledo

Faustini

S. E.

Marcial-Juarez

Shields

A. M.

Goodall

Allen

J. D.

Watanabe

Newby

M. L.

Crispin

Drayson

M. T.

Cunningham

A. F.

Richter

A. G.

O’Shea

M. K.

(2020). Sensitive detection of SARS-CoV-2-Specific antibodies in dried blood spot samples. Emerging Infectious Diseases, 26(12), 2970–2973. https://doi.org/10.3201/EID2612.203309

29.

Paterson

Meurice

Stanberry

L. R.

Glismann

Rosenthal

S. L.

Larson

H. J.

(2016). Vaccine hesitancy and healthcare providers. Vaccine, 34(52), 6700–6706. https://doi.org/10.1016/j.vaccine.2016.10.042

30.

Pennycook

McPhetres

Zhang

J. G.

Rand

D. G.

(2020). Fighting COVID-19 misinformation on social media: Experimental evidence for a scalable accuracy-nudge intervention. Psychological Science, 31(7), 770–780. https://doi.org/10.1177/0956797620939054

31.

Reno

Maietti

Fantini

M. P.

Savoia

Manzoli

Montalti

Gori

(2021). Enhancing COVID-19 vaccines acceptance: Results from a survey on vaccine hesitancy in northern Italy. Vaccines, 9(4), Article 378. https://doi.org/10.3390/vaccines9040378

32.

Riad

Sağıroğlu

Üstün

Pokorná

Klugarová

Attia

Klugar

(2021). Prevalence and risk factors of CoronaVac side effects: An independent cross-sectional study among healthcare workers in Turkey. Journal of Clinical Medicine, 10(12), Article 2629. https://doi.org/10.3390/jcm10122629

33.

Rief

(2021). Fear of adverse effects and COVID-19 vaccine hesitancy: Recommendations of the treatment expectation expert group. JAMA Health Forum, 2(4), Article e210804. https://doi.org/10.1001/JAMAHEALTHFORUM.2021.0804

34.

Rief

Avorn

Barsky

A. J.

(2006). Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects. Archives of Internal Medicine, 166(2), 155–160. https://doi.org/10.1001/archinte.166.2.155

35.

Sadeghalvad

Mansourabadi

A. H.

Noori

Nejadghaderi

S. A.

Masoomikarimi

Alimohammadi

Rezaei

(2022). Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies. Reviews in Medical Virology, 33, Article e2359. https://doi.org/10.1002/rmv.2359

36.

Schwarzinger

Watson

Arwidson

Alla

Luchini

(2021). COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. The Lancet Public Health, 6(4), e210–e221. https://doi.org/10.1016/S2468-2667(21)00012-8

37.

Smith

L. E.

Sim

Amlôt

Cutts

Dasch

Sevdalis

Rubin

G. J.

Sherman

S. M.

(2022). Side-effect expectations from COVID-19 vaccination: Findings from a nationally representative cross-sectional survey (CoVAccS – wave 2). Journal of Psychosomatic Research, 152, Article 110679. https://doi.org/10.1016/j.jpsychores.2021.110679

38.

Smith

L. E.

Webster

R. K.

Rubin

G. J.

(2020). A systematic review of factors associated with side-effect expectations from medical interventions. Health Expectations, 23(4), 731–758. https://doi.org/10.1111/hex.13059

39.

Sullivan

M. J. L.

Bishop

S. R.

Pivik

(1995). The Pain Catastrophizing Scale: Development and validation. Psychological Assessment, 7(4), 524–532. https://doi.org/10.1037/1040-3590.7.4.524

40.

Turgeon

C. T.

Sanders

K. A.

Granger

Nett

S. L.

Hilgart

Matern

Theel

E. S.

(2021). Detection of SARS-CoV-2 IgG antibodies in dried blood spots. Diagnostic Microbiology and Infectious Disease, 101(1), Article 115425. https://doi.org/10.1016/j.diagmicrobio.2021.115425

41.

Walsh

E. E.

Frenck

R. W.

Falsey

A. R.

Kitchin

Absalon

Gurtman

Lockhart

Neuzil

Mulligan

M. J.

Bailey

Swanson

K. A.

Koury

Kalina

Cooper

Fontes-Garfias

Shi

P.-Y.

Türeci

Ö.

Tompkins

K. R.

. . . Gruber

W. C.

(2020). Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. New England Journal of Medicine, 383(25), 2439–2450. https://doi.org/10.1056/nejmoa2027906

42.

Webster

R. K.

Weinman

James Rubin

(2016). A systematic review of factors that contribute to nocebo effects. Health Psychology, 35(12), 1334–1355. https://doi.org/10.1037/hea0000416

43.

Zinn

J. O.

(2008). Heading into the unknown: Everyday strategies for managing risk and uncertainty. Health, Risk & Society, 10(5), 439–450. https://doi.org/10.1080/13698570802380891

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB